These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28340227)

  • 1. Transplant as a competing risk in the analysis of dialysis patients.
    van Geloven N; le Cessie S; Dekker FW; Putter H
    Nephrol Dial Transplant; 2017 Apr; 32(suppl_2):ii53-ii59. PubMed ID: 28340227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When do we need competing risks methods for survival analysis in nephrology?
    Noordzij M; Leffondré K; van Stralen KJ; Zoccali C; Dekker FW; Jager KJ
    Nephrol Dial Transplant; 2013 Nov; 28(11):2670-7. PubMed ID: 23975843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritonitis-free survival in peritoneal dialysis: an update taking competing risks into account.
    Evans DW; Ryckelynck JP; Fabre E; Verger C
    Nephrol Dial Transplant; 2010 Jul; 25(7):2315-22. PubMed ID: 20103502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling competing risks in nephrology research: an example in peritoneal dialysis.
    Teixeira L; Rodrigues A; Carvalho MJ; Cabrita A; Mendonça D
    BMC Nephrol; 2013 May; 14():110. PubMed ID: 23705871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overestimation of the probability of death on peritoneal dialysis by the Kaplan-Meier method: advantages of a competing risks approach.
    Beuscart JB; Pagniez D; Boulanger E; Lessore de Sainte Foy C; Salleron J; Frimat L; Duhamel A
    BMC Nephrol; 2012 May; 13():31. PubMed ID: 22646159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaplan-Meier Survival Analysis Overestimates the Risk of Revision Arthroplasty: A Meta-analysis.
    Lacny S; Wilson T; Clement F; Roberts DJ; Faris PD; Ghali WA; Marshall DA
    Clin Orthop Relat Res; 2015 Nov; 473(11):3431-42. PubMed ID: 25804881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to the Analysis of Survival Data in the Presence of Competing Risks.
    Austin PC; Lee DS; Fine JP
    Circulation; 2016 Feb; 133(6):601-9. PubMed ID: 26858290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
    de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competing events influence estimated survival probability: when is Kaplan-Meier analysis appropriate?
    Biau DJ; Latouche A; Porcher R
    Clin Orthop Relat Res; 2007 Sep; 462():229-33. PubMed ID: 17496556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early failure in patients starting peritoneal dialysis: a competing risks approach.
    Béchade C; Guittet L; Evans D; Verger C; Ryckelynck JP; Lobbedez T
    Nephrol Dial Transplant; 2014 Nov; 29(11):2127-35. PubMed ID: 24071660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method.
    Verduijn M; Grootendorst DC; Dekker FW; Jager KJ; le Cessie S
    Nephrol Dial Transplant; 2011 Jan; 26(1):56-61. PubMed ID: 21059831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and time-to-transplantation of peritoneal dialysis versus hemodialysis for end-stage renal disease patients: competing-risks regression model in a single Italian center experience.
    Rigoni M; Torri E; Nollo G; Zarantonello D; Laudon A; Sottini L; Guarrera GM; Brunori G
    J Nephrol; 2017 Jun; 30(3):441-447. PubMed ID: 27900718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative incidence in competing risks data and competing risks regression analysis.
    Kim HT
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A note on competing risks in survival data analysis.
    Satagopan JM; Ben-Porat L; Berwick M; Robson M; Kutler D; Auerbach AD
    Br J Cancer; 2004 Oct; 91(7):1229-35. PubMed ID: 15305188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method.
    Zhu X; Kranse R; Bul M; Bangma CH; Schröder FH; Roobol MJ
    Can J Urol; 2013 Jun; 20(3):6756-60. PubMed ID: 23783043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival Analysis in the Presence of Competing Risks: The Example of Waitlisted Kidney Transplant Candidates.
    Sapir-Pichhadze R; Pintilie M; Tinckam KJ; Laupacis A; Logan AG; Beyene J; Kim SJ
    Am J Transplant; 2016 Jul; 16(7):1958-66. PubMed ID: 26751409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
    Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaplan-Meier methods yielded misleading results in competing risk scenarios.
    Southern DA; Faris PD; Brant R; Galbraith PD; Norris CM; Knudtson ML; Ghali WA;
    J Clin Epidemiol; 2006 Oct; 59(10):1110-4. PubMed ID: 16980152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.